StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJun 8, 2026, 02:26 PM

eXoZymes Prices Public Offering of Units at $18.00

AI Summary

eXoZymes Inc. announced the pricing of a public offering of units, each comprising two shares of common stock and one warrant, at $18.00 per unit. The offering is expected to generate approximately $5.33 million in gross proceeds. The company plans to use the net proceeds for business development, research and development, and general corporate purposes. The warrants have specific terms regarding exercise price, reset provisions, and redemption.

Key Highlights

  • eXoZymes Inc. priced a public offering of 592,270 units at $18.00 per unit.
  • Each unit consists of two shares of common stock and one warrant to purchase one share of common stock.
  • Gross proceeds are expected to be approximately $5.33 million before expenses.
  • An over-allotment option for an additional 88,840 shares and 44,420 warrants was granted.
  • Warrants are exercisable at $11.24 per share, commencing one year after the offering, and expire five years from issuance.
  • The exercise price of warrants may reset to $0.001 if the company sells shares below $8.99 within 12 months.
  • Net proceeds will be used for NCT business development, R&D, general corporate purposes, working capital, and capital expenditures.